n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End
n-Lorem to share its [...]
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations
Article published in Nucleic [...]
Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine
Case study, published in [...]
CYTIVA PRESS RELEASE: Cytiva continues its support for n-Lorem Foundation
Donation will assist in [...]
n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors
Andrew Lo’s expertise in [...]
n-Lorem Foundation Welcomes New Member Alan Lotvin to its Board of Directors
Alan Lotvin’s expertise in [...]
n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024
This year’s colloquium will [...]
